Technologies are continuing to advance and cell and gene therapies (C>s) are fast becoming more widely recognized as treatments with significant potential. As a result, there are many growing opportunities for marketers to set themselves apart from traditional approaches to treatment.
C>s are uniquely focused on the patient, making effective communication with patients and their families crucial to their success. With plenty of misconceptions and apprehensions held by not only patients but the general public too, companies must tailor their communication strategies to address these concerns to overcome hesitation and improve treatment outcomes.
Utilizing the insights gathered from existing patient data is key to delivering targeted and meaningful communications strategies. For patients living with rare diseases, many of which may have been engaging with healthcare and treatments from a very young age, a sense of community with other patients is very important. However, some patients may feel that if they are “cured,” they will no longer be able to identify with the community that has supported them.
By understanding the specific concerns and wants of patients regarding C>s, companies can craft a communication plan that keeps patients engaged with their treatment while maintaining their sense of community.
Additionally, companies should leverage influencer marketing and advocacy by engaging patients in online communities and working to understand what they want to communicate about their condition. This can help increase awareness of the disease and the importance of C>s.
In a piece with Pharma Live, Ben Beckley, President of Evoke Mind+Matter, an Inizio company, explores the importance of standing out in the market and examines the potential opportunities for C> developers.
Read more: https://www.pharmalive.com/marketing-in-cell-and-gene-therapy-how-to-stand-out-from-the-crowd/
Jump to a slide with the slide dots.
From LED walls to real-time in-booth optimization, ASCO® 2025 uncovered how we should engage and evolve the congress experience.
Read moreIt’s been a few weeks since ASCO® 2025, but one moment from the podium still echoes in my mind - the possibility of curing metastatic cancer.
Read moreWith new therapies and personalized treatments helping patients live longer, the definition of success in oncology is evolving. Read more.
Read more